OUR RESEARCH FOCUS
Our research group aims to understand how stem cells react and adapt to stress, and decipher how the microenvironment contributes to cancer progression and relapse. Furthermore, we aim to identify unique and previously unknown biological weaknesses in malignant cells, with the ultimate goal of developing innovative therapeutic strategies to improve outcomes for patients living with cancer, with a particular focus on leukemia.
Apr 5, 2023
Collaborative work on novel gene therapy for multiple sclerosis
Delivery of Nogo receptor(1-310)-Fc, a therapeutic fusion protein has been successfully applied as a treatment in animal models of spinal cord injury, as a novel gene therapy for multiple sclerosis
Mar 23, 2023
New research on the role of STAT5 in aggressive leukemia
Aberrant activation of the protein STAT5 is frequently observed in aggressive forms of ALL. A team of CCMR principal investigators found STAT5 accelerates ALL progression & promotes tumour resistance to chemotherapy